StreetAlpha.app
Home › Stocks › LGND

Ligand Pharmaceuticals Inc (LGND)

Healthcare
$286.85
▼ −0.03%
LAST CLOSE · NOV 20

Ligand buys royalty rights in pharmaceutical products and earns income from its Captisol and NITRICIL technology platforms. It last closed at $286.85 on Nov 20, down 0.03% on the day. The next earnings report for LGND is expected around Thu, Feb 25, 2027. For the quarter ended Sep 2026, LGND reported EPS of -$1.43 on revenue of $78.7M, with revenue down 31.8% from a year ago. Over its last 8 reports the stock moved an average of 3.6% the session after earnings. Over the last 12 months LGND insiders bought $0 of stock on the open market and sold $36.5M, according to SEC Form 4 filings.

AI Auto Pilots
Is LGND in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold LGND.

Key Stats

Last 12 months
Results
Revenue
$253.8M
+1.0% vs a year ago
Net income
$51.5M
+5.9% vs a year ago
EPS (diluted)
$2.49
+9.7% vs a year ago
Free cash flow
$90.6M
35.7% margin
Valuation
Market cap
$5.7B
20.0M shares
P/E
115.2
Price over 12 month EPS
Price to sales
22.6
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$56.0M
At Sep 30
Debt
$1.1B
At Sep 30
Shareholder equity
$961.8M
Buybacks
$60.0M
Last 12 months
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $241.5M$241.5MFY2021FY2022: $196.2M$196.2MFY2022FY2023: $131.3M$131.3MFY2023FY2024: $167.1M$167.1MFY2024FY2025: $268.1M$268.1MFY2025

From LGND's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 30). Last 12 months adds up the four latest quarters.

Next report
Feb 25
Estimated date · Time not announced
Reported EPS
-$1.43
Quarter ended Sep 2026
Year ago EPS
$5.68
−125.2% on a GAAP basis
Revenue
$78.7M
−31.8% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$1.68Dec '24Mar 2025: -$2.21Mar '25Jun 2025: $0.24Jun '25Sep 2025: $5.68Sep '25Dec 2025: $2.18Dec '25Mar 2026: -$0.67Mar '26Jun 2026: $2.22Jun '26Sep 2026: -$1.43Sep '26Latest -$1.43
Revenue by quarter
Dec 2024: $42.8MDec '24Mar 2025: $45.3MMar '25Jun 2025: $47.6MJun '25Sep 2025: $115.5MSep '25Dec 2025: $59.7MDec '25Mar 2026: $51.7MMar '26Jun 2026: $63.7MJun '26Sep 2026: $78.7MSep '26Latest $78.7M
How LGND moved after its last 8 reports
Average move the session after a report ±3.6%
Oct 29, 2026Time not announced−0.5%
Aug 6, 2026Time not announced−0.8%
May 7, 2026Time not announced−9.6%
Feb 26, 2026Time not announced+2.5%
Nov 6, 2025Time not announced+9.4%
Aug 7, 2025Time not announced+2.8%
May 8, 2025Time not announced−2.9%
Feb 27, 2025Time not announced+0.6%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on LGNDStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on LGND
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on LGND

Technical Analysis

LGND · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend

The stock is 7% below its 20 day and 5% below its 50 day average. It is 9% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 39). The nearest support is the swing low (Aug 7) at $286.65, and the nearest resistance the Pivot at $286.86.

Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityNormal, 4.0%/day
Key levels
$326.6352 week high+13.9%
$307.9520 day average+7.4%
$302.3550 day average+5.4%
$298.98100 day average+4.2%
$291.35Pivot R1+1.6%
$290.41Swing high (Sep 1)+1.2%
$286.86Pivot+0.0%
$286.85Last close
$286.65Swing low (Aug 7)−0.1%
$282.36Pivot S1−1.6%
$260.82200 day average−9.1%
$175.8952 week low−38.7%
Indicators
RSI (14)38.84Weak, oversold below 30Neutral
MACD-2.93Below its signal lineBearish
Stochastic11.1Near the bottom of its rangeOversold
ADX (14)17.5No clear trend
Williams %R-89.7Oversold below −80, overbought above −20Oversold
CCI (20)-192.2Oversold below −100, overbought above 100Oversold
Rate of change−6.3%Change over 10 sessionsBearish
ATR (14)$11.36Typical daily range, 4.0% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
What happened before, for LGND

What happened before

See how LGND did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow LGND usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How LGND has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2010.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for LGNDHow many large options trades hit LGND, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

LGND Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ●208 buying vs 190 selling
  • ▲Held by funds +2.5 pts
  • ▲Funds holding +17
  • ▲Superinvestors: 3 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding434417+4.1%
In funds' top 101213−7.7%
Held by funds115.8%113.3%+2.5 pts
New / increased62 / 14693 / 150−14.4%
Reduced / sold out145 / 45112 / 37+27.5%
Put/call ratio0.520.39+32.1%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See LGND institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

LGND Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$36.5M33 sales · 8 insiders
70% of the selling was under pre-arranged trading plans.
2025-12 sold $431K2026-01 sold $89K2026-02 sold $91K2026-03 sold $5.6M2026-04 sold $1.1M2026-05 sold $1.7M2026-06 sold $5.7M2026-07 sold $1.6M2026-08 sold $12.8M2026-09 sold $1.8M2026-10 sold $1.5M2026-11 sold $4.1MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 12John W KozarichDirectorSale plan500$325.00$163K
Nov 12Martine ZimmermannDirectorSale2,000$318.17$636K
Nov 10Jason AryehDirectorSale3,000$320.05$960K
Nov 4Jason AryehDirectorSale282$319.99$90K
Nov 2Andrew ReardonCLO & SecretarySale plan5,000$313.22$1.6M
Nov 2Jason AryehDirectorSale2,111$320.30$676K
Every insider buy and sale for LGND over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See LGND insider trades →

From SEC Form 4 filings by LGND's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether LGND is in one of them and how their past LGND trades turned out.

LGND in the AI portfolios
Loading…

LGND News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered LGND in an article yet. Here's the latest on the wider market.

LGND in the news

LGND Congress Trades

All congress trades →
Trades, 12 months
4
Buys
4
100%
Sells
0
0%
People
1
Last filed Jun 8
Who traded LGND · since 2017
Latest 5 filings of 9
$1K – $15KTraded May 29, 2026Filed Jun 8, 2026
$1K – $15KTraded Mar 3, 2026Filed Apr 7, 2026
$1K – $15KTraded Jan 15, 2026Filed Feb 13, 2026
$1K – $15KTraded Jan 5, 2026Filed Feb 13, 2026
$1K – $15KTraded Oct 22, 2020Filed Dec 3, 2020
PersonTypeAmountTradedFiledDelay
Gilbert CisnerosD · CABuy$1K – $15KMay 29, 2026Jun 8, 202610 d
Gilbert CisnerosD · CABuy$1K – $15KMar 3, 2026Apr 7, 202635 d
Gilbert CisnerosD · CABuy$1K – $15KJan 15, 2026Feb 13, 202629 d
Gilbert CisnerosD · CABuy$1K – $15KJan 5, 2026Feb 13, 202639 d
Katherine ClarkD · MASell$1K – $15KOct 22, 2020Dec 3, 202042 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data

About Ligand Pharmaceuticals

Ligand is a biopharmaceutical royalty company based in San Diego, California. It buys and structures royalty interests in medicines that are in clinical development or already on the market, earning income from sales made by partner drugmakers. It also earns royalties and material sales from its Captisol and NITRICIL technology platforms. Its customers are mainly biopharmaceutical companies that develop and sell the medicines tied to its royalty streams.

Headquarters
San Diego, CA